Your browser doesn't support javascript.
loading
Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases.
Desai, Dimpi; Rao, Devika; Sukrithan, Vineeth; Weinstein, Eleanor; Goyal, Akankasha; Schubart, Ulrich.
Afiliación
  • Desai D; Jacobi Medical Center, Bronx, NY, USA.
  • Rao D; Montefiore Hospital and Medical Center, Bronx, NY, USA.
  • Sukrithan V; Jacobi Medical Center, Bronx, NY, USA.
  • Weinstein E; Jacobi Medical Center, Bronx, NY, USA.
  • Goyal A; NYU Langone Medical Center, New York, NY, USA.
  • Schubart U; Jacobi Medical Center, Bronx, NY, USA.
J Investig Med High Impact Case Rep ; 5(2): 2324709617714286, 2017.
Article en En | MEDLINE | ID: mdl-28634594
Pancreatic ductal adenocarcinoma is the third leading cause of cancer-related death in the United States. Since it is usually diagnosed at an advanced stage, its prognosis remains poor. The initial presentation varies according to the tumor location. The most common presenting signs are weight loss, jaundice, and pain. Several epidemiological, clinical, and experimental studies over the past 2 decades have shown that long-standing diabetes is a modest risk factor for pancreatic cancer. However, new-onset diabetes has also been observed to be an early manifestation of pancreatic cancer. We report 2 cases where worsening glycemic control led to the diagnosis of pancreatic cancer.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Investig Med High Impact Case Rep Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Investig Med High Impact Case Rep Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos